| Code | 6715D | ||||||||||
| MA number | EU/1/08/442/031 | ||||||||||
| Product Form: | pqo por 30x180,4 mg+solv.28 ml+70 mg sukral.pr. (vre.PET/Al/LDPE+fľ.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 18.03.2008 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC Pradaxa 19 12 2012.pdf
|
| Dokument: |
dabigatran etexilát _Príručka pre predpisujúceho lekára CMP.PDF
|
| Dokument: |
dabigatran etexilát_Príručka pre predpisujúceho lekára VTE.PDF
|
| Dokument: |
Dabigatran Etexilát - Príručka pre predpisujúceho lekára.pdf
|
| Safety feature | Yes |
| Data update: | 27.01.2022 |
